Art

J-GLOBAL ID：201502224743304122   Reference number：15A0219915

Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout

痛風を併発または併発していない高尿酸血症のステージ3慢性腎臓疾患患者の血清尿酸レベルおよび尿中アルブミン排出量に及ぼすトピロキソスタットの影響

Author (8)： HOSOYA Tatsuo (Jikei Univ. School of Medicine, Tokyo, JPN) ,  OHNO Iwao (Jikei Univ. School of Medicine, Tokyo, JPN) ,  NOMURA Shinsuke (Suzuka Kaisei Hospital, Mie, JPN) ,  HISATOME Ichiro (Tottori Univ. Graduate School of Medical Sci., Tottori, JPN) ,  UCHIDA Shunya (Teikyo Univ. School of Medicine, Tokyo, JPN) ,  FUJIMORI Shin (Teikyo Univ. School of Medicine, Tokyo, JPN) ,  YAMAMOTO Tetsuya (Hyogo Coll. Medicine, Hyogo, JPN) ,  HARA Shigeko (Toranomon Hospital, Tokyo, JPN)
Material： Clinical and Experimental Nephrology  (Clin Exp Nephrol)
Volume： 18  Issue： 6  Page： 876-884  Publication year： Dec. 2014 
JST Material Number： L3173A  ISSN： 1342-1751  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： *hyperuricemia ,...
Semi thesaurus term： *Chronic renal diseases ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A0219915&from=J-GLOBAL&jstjournalNo=L3173A") }}

JST classification (3)： Treatment for metabolic diseases,nutritional diseases.  (GD05030F) ,  Clinical application of enzyme preparations and inhibitor preparations  (GW21020H) ,  Clinical medicine on urogenital system in general  (GM01030E)

Substance index (1)： Uric Acid

Reference (26)：

• Zhu Y, Pandya BJ, Choi HK. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. Am J Med. 2012;125:679-87.
• Iseki K, Oshiro S, Tozawa M, et al. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res. 2001;24:691-7.
• Chonchol M, Shlipak MG, Katz R, Sarnak M, et al. Relationship of uric acid with progression of kidney disease. Am J Kidney Dis. 2007;50:239-47.
• Chang HY, Tung CW, Lee PH, et al. Hyperuricemia as an independent risk factor of chronic kidney disease in middle-aged and elderly population. Am J Med Sci. 2010;339:509-15.
• Yamanaka H, Japanese Society of Gout and Nucleic Acid Metabolism. Japanese guideline for the management of hyperuricemia and gout: second edition. Nucleosides Nucleotides Nucleic Acids. 2011;30:1018-29.

Terms in the title (11)： 痛風 ,  併発 ,  高尿酸血症 ,  ステージ ,  慢性腎臓疾患 ,  患者 ,  血清 ,  尿酸 ,  尿中アルブミン ,  排出量 ,  トピロキソスタット